EGFR and neoplasm: It translates to the overexpression of EGFR protein, which in turn leads to aberrant activation of several downstream signal regulation pathways such as RAS/RAF/MAPK and PI3K/AKT/mTOR and STAT signaling pathway etc., and consequently promotes tumor occurrence and progression even in the presence of EGFR TKI.